Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer

NCT00424164 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: lapatinib ditosylate
DRUG: tamoxifen citrate
OTHER: pharmacological study

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC